Skip to content

Different pulmonary retentions in Holmium Laser Lithotripsy surgery under General Anesthesia using Laryngeal Mask Airway

Different pulmonary retentions in Holmium Laser Lithotripsy surgery under General Anesthesia using Laryngeal Mask Airway: a single-center, prospective, randomized, controlled clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030815
Enrollment
Unknown
Registered
2020-03-15
Start date
2020-03-02
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The changes of respiration and circulation and Disease Postoperative Pulmonary Complications

Interventions

Group A:VT: 6ml/kg, frequency 12-18/min. Pulmonary retentions for 30 s, only once
Group B:VT: 6ml/kg, frequency 12-18/min. Pulmonary retentions for 10 s, three times
Group C : VT: 6ml/kg, frequency 12-18/min. No pulmonary duplication

Sponsors

The General Hospital of Western Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) ASA grade I-III, Patients undergoing holmium laser lithotripsy under elective general anesthesia,the operation time was 1 to 3 hours; (2) Aged 18-65 years, Body mass index, BMI 18-30 kg/m2; (3) Preoperative lung function was normal; (4) Pregnancy test negative for women of childbearing age; (5) Voluntarily accepted general anesthesia and participated in the study.

Exclusion criteria

Exclusion criteria: (1) History of previous serious neuromuscular diseases, cardiovascular diseasesliver and kidney dysfunction (2) Patients with severe chest diseases and history of chronic respiratory diseases ; (3) Alcoholics, long-term sedatives, opioid addicts; (4) Those who have participated in other drugs clinical researches in recent three months; (5) With mental system disease, Normal ability of communication; (6) With previous history of severe allergy; (7) Researchers evaluate who is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications, include respiratory failure, pulmonary infection, pleural effusion, atelectasis, pneumothorax, bronchospasm, aspiration pneumonia, and pulmonary embolism Intraoperative circulatory indicators include: HR, SBP, DPB, MBP;arterial blood gas analysis;Heart rate (HR), Mean arterial pressure (Mbp);

Secondary

MeasureTime frame
Tidal volume (TV);Airway peak;Airway mean pressure (Pmean);Respiratory rate (RR);Breathe out at the end of the carbon dioxide (PetCO2);

Countries

China

Contacts

Public ContactWu Wei

The General Hospital of Western Theater Command

wuweizj@163.com+86 13008107300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026